XML 22 R10.htm IDEA: XBRL DOCUMENT
v3.25.1

Note 2 - Acquisition | 12 Months Ended
--- | ---
Dec. 31, 2024
Notes to Financial Statements |
Business Combination Disclosure [Text Block] | Note 2 – Acquisition On October 31, 2024, the Company completed the acquisition of all issued and outstanding shares of Electrochem Solutions, Inc., a Massachusetts corporation (“Electrochem”), pursuant to a stock purchase agreement (the “Agreement”) with Greatbatch Ltd., a New York corporation (the “Seller”), dated September 27, 2024 (the “Acquisition”). The Agreement established a purchase price of $50,000 for the Acquisition subject to customary working capital adjustments. The Company completed the Acquisition for $48,022 in cash, inclusive of working capital adjustments of $1,978. Based in Raynham, MA and with over forty years of battery technology experience in critical applications, Electrochem designs and manufactures primary lithium metal and ultracapacitor cells and battery packs serving energy, military and various environmental, industrial and utility end markets on a global basis. Acquiring Electrochem advances our strategy of more fully realizing the operating leverage of our business model through scale and manufacturing cost efficiencies. Electrochem brings a blue-chip customer base with little or no overlap with Ultralife’s customers, long-tenured technical resources which we plan to utilize in progressing our global new product initiatives, and a complimentary portfolio of highly engineered thionyl, sulfuryl and bromine chloride cells and packs which can be commercially cost prohibitive to substitute or switch out. We view this acquisition as an avenue to create highly attractive opportunities to drive revenue growth through heightened cross-selling platforms and extend our reach into underserved adjacent markets that demand uncompromised safety, service, reliability and quality. In addition, the combination of Electrochem and Ultralife creates achievable opportunities for gross margin expansion through the realization of vertical integration, supply chain synergies and lean initiatives. With Electrochem we are increasing our value to our customers and significantly strengthening our competitive position in our end markets. The Company funded the purchase price for the Acquisition through the New Credit Agreement (refer to Note 3). The Acquisition was accounted for in accordance with the accounting treatment of a business combination pursuant to FASB ASC Topic 805, Business Combinations (“ASC 805”). Accordingly, the purchase price was allocated to the tangible and intangible assets acquired and the liabilities assumed based on their estimated fair values on the acquisition date. The excess of the purchase price over the estimated fair value of the separately identifiable assets acquired and liabilities assumed was allocated to goodwill. Management is responsible for determining the acquisition date fair value of the assets acquired and liabilities assumed, which requires the use of various assumptions and judgments that are inherently subjective. The purchase price allocation presented below reflects all known information about the fair value of the assets acquired and liabilities assumed as of the acquisition date. The purchase price allocation is subject to change should additional information existing as of the acquisition date about the fair value of the assets acquired and liabilities assumed become known. The final purchase price allocation may reflect material changes in the valuation of assets acquired and liabilities assumed, including but not limited to intangible assets, fixed assets, deferred taxes, and residual goodwill.
Accounts receivable |  | $ | 5,270 |
Inventories |  |  | 9,172 |
Prepaid expenses and other current assets |  |  | 251 |
Property, plant and equipment |  |  | 20,735 |
Goodwill |  |  | 7,558 |
Other intangible assets |  |  | 10,500 |
Other noncurrent assets |  |  | 237 |
Accounts payable |  |  | (2,231 | )
Accrued compensation and related benefits |  |  | (1,561 | )
Accrued expenses and other current liabilities |  |  | (904 | )
Deferred tax liability, net |  |  | (748 | )
Other noncurrent liabilities |  |  | (257 | )
Net assets acquired |  | $ | 48,022 |
The goodwill included in the Company’s purchase price allocation presented above represents the value of Electrochem’s assembled and trained workforce, the incremental value that Excell engineering and technology will bring to the Company and the revenue growth which is expected to occur over time which is attributable to increased market penetration from future new products and customers. The goodwill acquired in connection with the acquisition is not deductible for income tax purposes. Other intangible assets were valued using the income approach which requires a forecast of all expected future cash flows and the use of certain assumptions and estimates. The following table summarizes the estimated fair value and annual amortization for each of the identifiable intangible assets acquired.
|  |  |  |  |  |  |  |  |  | Annual Amortization |
|  | Estimated Fair Value |  |  | Amortization Period (Years) |  |  | Year 1 |  |  | Year 2 |  |  | Year 3 |  |  | Year 4 |  |  | Year 5 |
Trade name |  | $ | 5,300 |  |  |  | 15 |  |  | $ | 353 |  |  | $ | 353 |  |  | $ | 353 |  |  | $ | 353 |  |  | $ | 353 |
Customer relationships |  |  | 5,100 |  |  |  | 15 |  |  |  | 340 |  |  |  | 340 |  |  |  | 340 |  |  |  | 340 |  |  |  | 340 |
Patents and technology |  |  | 100 |  |  |  | 5 |  |  |  | 20 |  |  |  | 20 |  |  |  | 20 |  |  |  | 20 |  |  |  | 20 |
Total |  | $ | 10,500 |  |  |  |  |  |  | $ | 713 |  |  | $ | 713 |  |  | $ | 713 |  |  | $ | 713 |  |  | $ | 713 |
We acquired right-of-use assets and assumed operating lease liabilities of $230. Right-of-use assets are classified as other noncurrent assets, and current and long-term lease liabilities are classified as accrued expenses and other current liabilities and other noncurrent liabilities, respectively, on the Company’s consolidated balance sheets. The operating results and cash flows of Electrochem are reflected in the Company’s consolidated financial statements from the date of acquisition. Electrochem is included in the Battery & Energy Products segment. For the year ended December 31, 2024, subsequent to the October 31, 2024 acquisition date, Electrochem contributed revenue of $6,062 and net income of $932, inclusive of a $120 increase in cost of products sold for the fair value step-up of acquired finished goods inventory sold during the period, and amortization expense of $119 on acquired identifiable intangible assets. During the year ended December 31, 2024, the Company incurred transaction costs and other non-recurring expenses of $1,294 directly attributable to the acquisition, including one-time accounting, legal and due diligence services. These costs are included in selling, general and administrative expense on the consolidated statement of income and comprehensive income for the year ended December 31, 2024. The following supplemental pro forma information presents the combined results of operations, inclusive of the acquisition accounting adjustments and one-time expenses described above, as if the acquisition of Electrochem had been completed on January 1, 2023, the beginning of the comparable prior period. The supplemental pro forma results do not reflect the realization of potential synergies or other cost reductions following the completion of the business combination. The supplemental pro forma results are presented for informational purposes only and should not be considered indicative of the financial position or results of operations had the acquisition been completed as of the dates indicated and does not purport to indicate the future combined financial position or results of operation. Set forth below are the unaudited supplemental pro forma results of the Company and Electrochem for the years ended December 31, 2024 and 2023 as if the acquisition had occurred as of January 1, 2023.
|  | Year Ended December 31, |
|  | 2024 |  |  | 2023 |
Revenue |  | $ | 188,724 |  |  | $ | 197,777 |
Operating income |  |  | 9,139 |  |  |  | 7,350 |
Net income attributable to Ultralife Corporation |  |  | 3,618 |  |  |  | 2,780 |
Net income per share attributable to Ultralife Corporation: |  |  |  |  |  |  |  |
Basic |  | $ | .22 |  |  | $ | .17 |
Diluted |  | $ | .22 |  |  | $ | .17 |

X
- Definition The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/805/tableOfContent + Details
Name: | us-gaap_BusinessCombinationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration